Chromosomal instability, colorectal cancer and taxane resistance.
about
BCL9L Dysfunction Impairs Caspase-2 Expression Permitting Aneuploidy Tolerance in Colorectal CancerPhase II clinical trial of ixabepilone in patients with recurrent or persistent platinum- and taxane-resistant ovarian or primary peritoneal cancer: a gynecologic oncology group study.A high throughput, whole cell screen for small molecule inhibitors of the mitotic spindle checkpoint identifies OM137, a novel Aurora kinase inhibitorThe role of chromosome missegregation in cancer development: a theoretical approach using agent-based modellingUsp7 protects genomic stability by regulating Bub3.Establishment and characterization of cell lines from chromosomal instable colorectal cancer.Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells.Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery.Chromosomal instability as a prognostic marker in cervical cancer.Chromosomal instability substantiates poor prognosis in patients with diffuse large B-cell lymphoma.Predictive and prognostic values of BubR1 and synuclein-gamma expression in breast cancerA set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemiaEvaluation of activity and combination strategies with the microtubule-targeting drug sagopilone in breast cancer cell lines.Targeting synuclein-gamma to counteract drug resistance in cancer.Styrene maleic acid-encapsulated paclitaxel micelles: antitumor activity and toxicity studies following oral administration in a murine orthotopic colon cancer model.Chromosomal instability determines taxane responsePharmacoepigenomics in colorectal cancer: a step forward in predicting prognosis and treatment response.Heterogeneity of adenosine triphosphate-based chemotherapy response assay in colorectal cancer--secondary publication.Molecular classification of solid tumours: towards pathway-driven therapeuticsCellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitroRNAi-mediated functional analysis of pathways influencing cancer cell drug resistance.Mismatch repair deficient colorectal cancer in the era of personalized treatment.Patupilone in cancer treatment.Cell cycle modulatory and apoptotic effects of plant-derived anticancer drugs in clinical use or development.Individualized therapy for metastatic colorectal cancer.Taxane benefit in breast cancer--a role for grade and chromosomal stability.Anticancer effects of seaweed compounds fucoxanthin and phloroglucinol, alone and in combination with 5-fluorouracil in colon cells.Diaminothiazoles evade multidrug resistance in cancer cells and xenograft tumour models and develop transient specific resistance: understanding the basis of broad-spectrum versus specific resistance.Advances in Biomarkers: Going Beyond the Carcinoembryonic Antigen.Shugoshin1 enhances multidrug resistance of gastric cancer cells by regulating MRP1, Bcl-2, and Bax genes.Correlation of Early Recurrence With In Vitro Adenosine Triphosphate Based Chemotherapy Response Assay in Pancreas Cancer With Postoperative Gemcitabine Chemotherapy.Chromosome 20q amplification regulates in vitro response to Kinesin-5 inhibitor.SIRT2 knockdown increases basal autophagy and prevents postslippage death by abnormally prolonging the mitotic arrest that is induced by microtubule inhibitors.Novel application of multicellular layers culture for in situ evaluation of cytotoxicity and penetration of paclitaxel.Comprehensive Analysis of Cancer-Proteogenome to Identify Biomarkers for the Early Diagnosis and Prognosis of Cancer.A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo.Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer.High frequency of TTK mutations in microsatellite-unstable colorectal cancer and evaluation of their effect on spindle assembly checkpoint.Patupilone in patients with pretreated metastatic/locally recurrent colorectal cancer: results of the Phase II CINATRA trialEpothilones and new analogues of the microtubule modulators in taxane-resistant disease
P2860
Q28468367-1F8C7E6F-418E-4F28-BEE6-6198C59DB7A6Q30433670-D57DFD53-B801-449D-9463-A586244848D4Q30437056-242316A8-CB75-40FB-AAC3-23799E390010Q31132456-0A4B8FE8-0EC5-44BE-8884-DC91A6F81D67Q33977038-E083220B-4378-40E5-A507-C4EB8D7B1948Q34827208-AA97196D-4732-42F2-B492-DDA6DF141745Q35497999-587492C4-F2DD-47B7-8614-9098C8BB9F91Q35583987-9CD5984D-9957-429D-8CAC-CBB4C6C87854Q35610374-B1F39F10-C9D9-4173-AF62-7AFF37556D63Q35630295-A0CB25EF-606F-4E86-B751-832625EEC11BQ35854162-0C22BDD4-CB9B-45E0-A317-05D69A49F677Q35925051-F65A070E-9D7A-4075-BE92-B63458D51B69Q35971203-D21DF943-05A8-47C0-8DBF-53A500C44BE0Q37030872-BB0ABD3D-B620-49FF-9A67-02923C0DA6C8Q37194117-02DE871D-7798-4529-9F4D-7BA7689B59EEQ37208871-766EFAD3-1D78-4802-AF00-673CDC7C749EQ37346216-9729586F-CF6C-412C-94C4-4C63FADDED9EQ37400987-763FB0BE-28AD-4F97-BA45-993ADCAD32A8Q37444718-F85DCD06-8FD1-482E-9200-6E5ACB16A4B5Q37457681-C525D14A-6B58-4F65-B3C3-3E3A7C61E1ACQ37494793-18B5FC51-2F33-44EE-93D3-CD19CA05A774Q37696965-49E3599B-0165-45FE-BDE4-306986D09498Q37818255-605CC061-C2C4-431A-BDC0-D1A4CAD5D8B7Q38088759-DFC36BCB-3765-4535-B931-7B71D811F5EDQ38092886-8BACF8EF-7E7A-4545-8649-74C36EF8D4C8Q38104568-8E1D3686-12B6-45A2-B28F-56E8705B8D35Q38693910-8AE25C11-7F81-4B89-857D-771B9DFC7A45Q38870594-81809E92-BB0C-4914-AB42-D5640FB3DF98Q38943220-BF046E67-240D-42D7-8F70-74E73DCD8763Q39169792-94D5D0CE-D727-43AE-A29F-40E9A28A55EFQ40511283-FBD0DCA7-9AB9-4DC1-85AD-A7393AA265BBQ41914377-0B79C2E3-D090-4CA1-B67D-BFCF27D19195Q42457087-D7CE4071-352B-4970-BBBB-9DE8E57F5AB4Q46756188-16CC625B-B3BC-49E7-A9D2-41A5F6493627Q47606195-777ACAEB-0496-4012-A484-DC6BADBAACDDQ48165994-0226ACEE-1302-42E5-A258-93AA319EEE22Q50082515-56EDB60A-588C-4132-99F2-EF7476F081F3Q54396887-828B4097-D0DA-45BA-86B5-05FED03F3459Q57244848-1F76A69E-B70B-499D-A553-716017E9B3C2Q57244875-3DA1A336-0510-4125-906B-A3FA1F60D1D2
P2860
Chromosomal instability, colorectal cancer and taxane resistance.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Chromosomal instability, colorectal cancer and taxane resistance.
@ast
Chromosomal instability, colorectal cancer and taxane resistance.
@en
type
label
Chromosomal instability, colorectal cancer and taxane resistance.
@ast
Chromosomal instability, colorectal cancer and taxane resistance.
@en
prefLabel
Chromosomal instability, colorectal cancer and taxane resistance.
@ast
Chromosomal instability, colorectal cancer and taxane resistance.
@en
P50
P356
P1433
P1476
Chromosomal instability, colorectal cancer and taxane resistance.
@en
P304
P356
10.4161/CC.5.8.2682
P577
2006-04-17T00:00:00Z